Post-Discharge Outcomes of Elderly Patients Hospitalized for Inflammatory Bowel Disease Flare Complicated by Clostridioides difficile Infection

被引：0

作者：

Goren, Idan ^{[1
,2
]}

Boldes, Ortal Fallek ^{[3
]}

Boldes, Tomer ^{[4
]}

Knyazev, Oleg ^{[5
,6
]}

Kagramanova, Anna ^{[5
,7
]}

Limdi, Jimmy K. ^{[8
,9
]}

Liu, Eleanor ^{[9
]}

Sethi-Arora, Karishma ^{[8
]}

Holvoet, Tom ^{[10
,11
]}

Eder, Piotr ^{[12
]}

Bezzio, Cristina ^{[13
,14
]}

Saibeni, Simone ^{[15
]}

Vernero, Marta ^{[15
,16
]}

Alimenti, Eleonora ^{[15
,17
]}

Chaparro, Maria ^{[18
,19
]}

Gisbert, Javier P. ^{[18
,19
]}

Orfanoudaki, Eleni ^{[20
]}

Koutroubakis, Ioannis E. ^{[20
]}

Pugliese, Daniela ^{[21
]}

Cuccia, Giuseppe ^{[22
]}

Suarez, Cristina Calvino ^{[23
]}

Ribaldone, Davide Giuseppe ^{[17
]}

Veisman, Ido ^{[24
,25
]}

Sharif, Kassem ^{[24
,25
]}

Aratari, Annalisa ^{[26
,27
]}

Papi, Claudio ^{[26
,27
]}

Mylonas, Iordanis ^{[26
,27
]}

Mantzaris, Gerassimos J. ^{[26
,27
]}

Truyens, Marie ^{[27
]}

Ortega, Triana Lobaton ^{[28
]}

Nancey, Stephane ^{[29
]}

Castiglione, Fabiana ^{[30
]}

Nardone, Olga Maria ^{[31
]}

Calabrese, Giulio ^{[31
]}

Karmiris, Konstantinos ^{[32
]}

Velegraki, Magdalini ^{[32
]}

Theodoropoulou, Angeliki ^{[32
]}

Shitrit, Ariella Bar-Gil ^{[33
]}

Lukas, Milan ^{[34
,35
]}

Vojtechova, Gabriela ^{[34
,35
]}

Ellul, Pierre ^{[36
]}

Bugeja, Luke ^{[36
]}

Savarino, Edoardo, V ^{[37
]}

Fischler, Tali Sharar ^{[1
]}

Dotan, Iris ^{[1
]}

Yanai, Henit ^{[1
]}

机构：

[1] Tel Aviv Univ, Fac Med & Hlth Sci, Rabin Med Ctr, Div Gastroenterol, Tel Aviv, Israel

[2] SUNY Upstate Med Univ, Div Gastroenterol, Syracuse, NY 13210 USA

[3] Tel Aviv Univ, Fac Med & Hlth Sci, Rabin Med Ctr, Dept Internal Med E, Tel Aviv, Israel

[4] Tel Aviv Univ, Fac Med & Hlth Sci, Meir Med Ctr, Dept Otolaryngol, Tel Aviv, Israel

[5] Moscow Clin Sci Ctr, Moscow, Russia

[6] Natl Med Res Ctr Coloproctol, Moscow, Russia

[7] Res Inst Hlth Org & Med Management, Moscow, Russia

[8] Northern Care Alliance Hosp NHS Fdn Trust, Div Gastroenterol, Manchester, England

[9] Univ Manchester, Fac Biol Med & Hlth, Manchester, England

[10] VITAZ, Dept Gastroenterol, St Niklaas, Belgium

[11] Univ Hosp Ghent, Dept Gastroenterol, Ghent, Belgium

[12] Poznan Univ Med Sci, Dept Gastroenterol Dietet & Internal Med, Poznan, Poland

[13] IRCCS Humanitas Res Hosp, IBD Ctr, Milan, Italy

[14] Humanitas Univ, Dept Biomed Sci, Milan, Italy

[15] ASST RHODENSE, Dept Gastroenterol, Rho, Italy

[16] Univ Turin, Dept Med Sci, Turin, Italy

[17] Univ Pavia, Dept Med Sci, Gastroenterol Unit, Pavia, Italy

[18] Univ Autonoma Madrid, Hosp Univ La Princesa, Dept Gastroenterol, Inst Invest Sanitaria Princesa IIS Princesa, Madrid, Spain

[19] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain

[20] Univ Hosp Heraklion, Dept Gastroenterol, Iraklion, Greece

[21] Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Sci Med & Chirurg, CEMAD IBD UNIT Unita Operat Complessa Med Interna, Rome, Italy

[22] Univ Cattolica Sacro Cuore, Dipartimento Univ Med & Chirurg Traslaz, Rome, Italy

[23] Univ Hosp Santiago De Compostela, Dept Gastroenterol & Hepatol, La Coruna, Spain

[24] Tel Aviv Univ, Fac Med, Sheba Med Ctr, Dept Gastroenterol, Tel Aviv, Israel

[25] Dept Gastroenterol, Ramat Gan, Israel

[26] S Filippo Neri Hosp, Dept Gastroenterol, Gastroenterol, Rome, Italy

[27] Evangelismos Polyclin Gen Hosp, Dept Gastroenterol, Athens, Greece

[28] Univ Ghent, Dept Internal Med & Pediat, Ghent, Belgium

[29] Hosp Civils Lyon, South Lyon Univ Hosp, Dept Gastroenterol, Lyon, France

[30] Univ Naples Federico II, Dept Clin Med & Surg, Gastroenterol, Naples, Italy

[31] Univ Naples Federico II, Dept Publ Hlth, Gastroenterol, Naples, Italy

[32] Venizeleio Gen Hosp, Dept Gastroenterol, Iraklion, Greece

[33] Hebrew Univ Jerusalem, Digest Dis Inst, Shaare Zedek Med Ctr, IBD MOM Unit, Jerusalem, Israel

[34] Charles Univ Prague, Clin & Res Ctr Inflammatory Bowel Dis ISCARE, Prague, Czech Republic

[35] Charles Univ Prague, Fac Med 1, Prague, Czech Republic

[36] Mater Dei Hosp, Div Gastroenterol, Birkirkara, Malta

[37] Univ Padua, Dept Surg Oncol & Gastroenterol, Div Gastroenterol, Padua, Italy

来源：

JOURNAL OF CROHNS & COLITIS | 2024年

关键词：

Inflammatory bowel disease; Clostridioides difficile; elderly; hospitalization; outcomes; mortality; PATHOGEN; RELAPSE; BURDEN; COHORT; IMPACT; IBD;

D O I：

10.1093/ecco-jcc/jjae161

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Objectives: Elderly hospitalized patients with inflammatory bowel disease (IBD) flare and concurrent Clostridioides difficile infection (CDI) are considered at high risk of IBD-related complications. We aimed to evaluate the short-,intermediate-, and long-term post-discharge complications among these patients. Methods: A retrospective multicenter cohort study assessing outcomes of elderly individuals (>= 60 years) hospitalized for an IBD flare who were tested for CDI (either positive or negative) and discharged. The primary outcome was the 3-month post-discharge IBD-related complication rates defined as steroid dependency, re-admissions (emergency department or hospitalization), IBD-related surgery, or mortality. We assessed post-discharge IBD-related complications within 6 month and mortality at 12 month among secondary outcomes. Risk factors for complication were assessed by multivariable logistic regression. Results: In a cohort of 654 patients hospitalized for IBD {age 68.9 (interquartile range [IQR]): 63.9-75.2 years, 60.9% ulcerative colitis (UC)}, 23.4% were CDI-positive. Post-discharge complication rates at 3 and 6 months, and 12 months mortality, did not differ significantly between CDI-positive and CDI-negative patients (32% vs 33.1%, p = 0.8; 40.5% vs 42.5%, p = 0.66; and 4.6% vs 8%, p = 0.153, respectively). The Charlson comorbidity index was the only significant risk factor for complications within 3 months (aOR 1.1), whereas mesalamine (5-aminosalicylic acid [5-ASA]) use was protective (aOR 0.6). An UC diagnosis was the sole risk factor for complication at 6 months (aOR 1.5). Clostridioides difficile infection did not significantly impact outcomes or interact with IBD type. Conclusions: In elderly IBD patients hospitalized for IBD flare and subsequently discharged, a concurrent CDI infection was not associated with post-discharge IBD-related complications or mortality up to 1 year.

引用

页数：9

共 50 条

[31] Risk Factors, Diagnosis, and Management of Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease
Del Vecchio, Livio Enrico
Fiorani, Marcello
Tohumcu, Ege
Bibbo, Stefano
Porcari, Serena
Mele, Maria Cristina
Pizzoferrato, Marco
Gasbarrini, Antonio
Cammarota, Giovanni
Ianiro, Gianluca
MICROORGANISMS, 2022, 10 (07)
[32] Serum procalcitonin levels associate with Clostridioides difficile infection in patients with inflammatory bowel disease
Abdehagh, Mohammad
Azimirad, Masoumeh
Houri, Hamidreza
Nadalian, Banafsheh
Azimirad, Fahimeh
Olfatifar, Meysam
Shoeibi, Ome Kolsoum Nasir
Yadegar, Abbas
Shahrokh, Shabnam
Roshan, Mehran Mahdavi
Aghdaei, Hamid Asadzadeh
Zali, Mohammad Reza
BMC INFECTIOUS DISEASES, 2021, 21 (01)
[33] Clostridioides Infection in Patients with Inflammatory Bowel Disease
Lee, Mi Rae
Kim, Eun Soo
KOREAN JOURNAL OF GASTROENTEROLOGY, 2022, 80 (02): : 66 - 71
[34] Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease
Gupta, Annu
Wash, Christopher
Wu, Yingxing
Sorrentino, Dario
Nguyen, Vu Q.
DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (02) : 547 - 553
[35] Application of Procalcitonin for the Rapid Diagnosis of Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease
Xie, Shuhua
Chen, Peisong
Wang, Dong
Jiang, Xiaobing
Wu, Zhongwen
Liao, Kang
Liu, Min
Zhang, Shihong
Chen, Yili
DIAGNOSTICS, 2022, 12 (12)
[36] Serum procalcitonin levels associate with Clostridioides difficile infection in patients with inflammatory bowel disease
Mohammad Abdehagh
Masoumeh Azimirad
Hamidreza Houri
Banafsheh Nadalian
Fahimeh Azimirad
Meysam Olfatifar
Ome Kolsoum Nasir Shoeibi
Abbas Yadegar
Shabnam Shahrokh
Mehran Mahdavi Roshan
Hamid Asadzadeh Aghdaei
Mohammad Reza Zali
BMC Infectious Diseases, 21
[37] THE IMPACT OF IN-HOSPITAL OPIOID EXPOSURE ON POST-DISCHARGE OPIOID USE IN HOSPITALIZED PATIENTS WITH INFLAMMATORY BOWEL DISEASE
DeDecker, Lauren C.
Spartz, Ellen
Fansiwala, Kush M.
Noorian, Shaya
Roney, Andrew R.
Hubbard, Logan
Turkiewicz, Joanna
Gonzalez, Alejandro Sarabia
Dente, Elizabeth
Sauk, Jenny S.
Limketkai, Berkeley N.
GASTROENTEROLOGY, 2023, 164 (06) : S681 - S682
[38] ASSOCIATION OF CLOSTRIDIOIDES DIFFICILE INFECTION WITH THE USE OF CORTICOSTEROIDS AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Gandhi, Mustafa
Barffour, Maxwell
Chela, Harleen
Reznicek, Emily
Karanja, Elizabeth
Luton, Kevin
Bosak, Emily
Ghouri, Yezaz A.
GASTROENTEROLOGY, 2023, 164 (06) : S643 - S643
[39] Treatment outcomes of mild to moderate Clostridioides difficile infection in inflammatory bowel disease: an Australian experience
Jacob, Rachael
Chu, Virginia
Ng, Watson
Williams, Astrid-Jane
Connor, Susan
INTERNAL MEDICINE JOURNAL, 2024, 54 (12) : 2009 - 2014
[40] Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease
Annu Gupta
Christopher Wash
Yingxing Wu
Dario Sorrentino
Vu Q. Nguyen
Digestive Diseases and Sciences, 2021, 66 : 547 - 553

← 1 2 3 4 5 →